Sr. ADME and Quantitative Pharmacology Director

Let’s build the future of medicine - together.

Join Enveda as a Sr. ADME and Quantitative Pharmacology Director and help us transform natural compounds into life-changing medicines. We’re a team driven by curiosity and innovation - are you ready to make a difference?

Life is smart, and we can learn from it. We’re reinventing drug discovery by harnessing nature’s intelligence. Our platform identifies new medicines four times faster than the industry standard because patients can’t wait. What sets Enveda apart isn’t just what we do - it’s how we do it. Our culture is built on creativity, collaboration, and deep respect for each other. We believe “People Create All Value”, and our success is driven by the extraordinary team turning our mission into reality every day.

• Unicorn status: Achieved following a $150 million Series D funding round in 2025
• Discovery and innovation: Advanced our first drug candidate to Phase 1 trials in 2024
• Award-winning culture:
  • Newsweek: Top 100 Global #MostLovedWorkplaces (2025)
  • Forbes: America’s Best Startup Employers (2024 & 2025)
  • Newsweek: America’s Greatest Startup Workplaces (2025)
  • Fast Company: Most Innovative Companies in 2026

These milestones reflect the impact of our team and we’re just getting started, but they’re only possible because of the diverse talent, perspectives, and relentless drive of our team, and people like you.

At Enveda, every role drives impact. As the Sr. ADME and Quantitative Pharmacology Director, you’ll provide strategic leadership across DMPK, clinical pharmacology, and modeling & simulation for our expanding portfolio. You will be a key member of the AQP team, reporting to the VP, AQP, and will oversee DMPK and PK/PD activities from candidate nomination through clinical development - making significant contributions to integrated drug development strategy within a diverse R&D organization.

What You’ll Do

Lead DMPK and PK/PD strategy across discovery and development programs, from candidate nomination through clinical development and regulatory submission
Drive clinical pharmacology strategy including dose finding, exposure–response modeling, PK/PD analysis, and risk-benefit assessment for early- and late-stage programs
Oversee PK/PD study design, analysis, and interpretation, collaborating with clinical operations, biostatistics, and regulatory colleagues
Provide scientific and regulatory support for DMPK, Clinical Pharmacology, and Biopharmaceutics sections of regulatory submissions, including IND, NDA, and BLA filings
Act as the subject-matter expert for clinical pharmacology and DMPK in interactions with FDA, EMA, and other global health authorities
Partner with translational, discovery, and clinical teams to integrate nonclinical ADME data into clinical development plans and support compound progression from pipeline to early development
Work closely with Discovery and DMPK groups to provide PK/ADME support for discovery projects, enabling informed compound selection and optimization
Ensure alignment of DMPK and PK/PD activities with clinical development, drug manufacturing, and regulatory plans across the portfolio
Provide strategic and technical leadership to the AQP function on scientific matters, combining full-time and consulting resources
Plan and conduct stage-appropriate Clinical Pharmacology studies (Phase I/II/III) to support regulatory submissions

We’re Looking For

PhD, PharmD, or MD in Pharmacokinetics, Clinical Pharmacology, Pharmaceutical Sciences, or a related discipline with 15+ years of relevant experience in biotech or pharma
Demonstrated expertise in PK/PD, modeling & simulation, dose finding, and exposure-response strategies across nonclinical and clinical development
Strong knowledge of Health Authority regulations and guidelines (ICH, FDA, EMA) for the development of small molecule therapies, with expert knowledge of those relating to Clinical Pharmacology/PK/PD
Proven success representing Clinical Pharmacology and DMPK in regulatory interactions with FDA and ideally other regulators (e.g., FDA Pre-IND and EMA Scientific Advice meetings), and supporting IND, NDA, or BLA filings
Extensive familiarity with major CROs and the ability to manage collaborations with CROs, academia, and industry partners
Leadership experience managing teams and cross-functional collaborations, with excellent communication skills and the ability to influence at all levels from scientists to executive leadership
Ability to manage multiple therapeutic programs in parallel and prioritize according to the needs of the company while delivering on key milestones
Familiarity with non-oral small molecule delivery (formulation) approaches is a bonus; strong appreciation for research with a focus on product development